A review of the therapeutic potential of histone deacetylase inhibitors in rhabdomyosarcoma

• Omar Selim,
• Clara Song,
• Amy Kumar,
• Rebecca Phelan,
• Arun Singh,
• Noah Federman,
• Noah Federman,
• Noah Federman

Affiliations

Omar Selim

Clinical and Translational Science Institute, University of California, Los Angeles, CA, United States

Clara Song

Clinical and Translational Science Institute, University of California, Los Angeles, CA, United States

Amy Kumar

Clinical and Translational Science Institute, University of California, Los Angeles, CA, United States

Rebecca Phelan

Clinical and Translational Science Institute, University of California, Los Angeles, CA, United States

Arun Singh

Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, United States

Noah Federman

Clinical and Translational Science Institute, University of California, Los Angeles, CA, United States

Noah Federman

Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, CA, United States

Noah Federman

Department of Orthopaedic Surgery, David Geffen School of Medicine, University of California, Los Angeles, CA, United States